Table 5.
Sensitivity analysis 1 | Sensitivity analysis 2 | Sensitivity analysis 3 | Sensitivity analysis 4 | |
---|---|---|---|---|
Q1 | 1.00 | 1.00 | 1.00 | 1.00 |
Q2 | 1.04 (0.95,1.14) | 1.02 (0.93,1.12) | 1.11 (0.98,1.26) | 1.03 (0.94,1.13) |
Q3 | 1.13 (1.03,1.24) | 1.13 (1.03,1.24) | 1.17 (1.03,1.33) | 1.13 (1.03,1.23) |
Q4 | 1.18 (1.08,1.29) | 1.19 (1.06,1.28) | 1.42 (1.25,1.62) | 1.22 (1.12,1.34) |
P for Trend | <0.0001 | 0.0002 | <0.0001 | <0.0001 |
Adjusted for age (continuous variable, years), sex (categorical variable, men or women), LDL-C (as a continuous variable), HDL-C (as a continuous variable), hs-CRP (as a continuous variable), BMI (as a continuous variable), smoking status (as a categorical variable, yes or no), alcohol consumption status (as a categorical variable, yes or no), physical exercise habits (as a categorical variable, yes or no), educational level (as a categorical variable, high school or above vs. below high school level), hypertension (as a categorical variable, yes or no), the use of lipid-lowering drugs (as a categorical variable, yes or no, except sensitivity analysis 2), and TyG index (continuous variable) in baseline.
Sensitivity analysis 1: the exclusion of participants in whom diabetes developed within the first year of follow-up.
Sensitivity analysis 2: the exclusion of participants who were taking lipid-lowering or antihypertensive medication.
Sensitivity analysis 3: the exclusion of participants with TG ≥ 2.3 mmol/L in baseline.
Sensitivity analysis 4: adjusting for the baseline TG and FBG and without the inclusion of the baseline TyG-index.